CXCL13 and colorectal carcinoma: Our examination has culminated in the development of characteristic prognostic risk models incorporating chemokines (CCR10), CXCL13, CXCR6, and XCR1, thereby furnishing novel insights into the intricate landscape of the CRC immune microenvironment.